CM
CRSP icon

Caption Management’s CRISPR Therapeutics CRSP Stock Holding History

Caption Management’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$642K Sell
13,500
-80,000
-86% -$4.22M ﹤0.01% 1146
2025
Q4 		$4.9M Buy
93,500
+3,500
+4% +$210K 0.03% 527
2025
Q3 		$5.83M Buy
90,000
+60,000
+200% +$3.44M 0.05% 432
2025
Q2 		$1.46M Hold
30,000
– – 0.02% 819
2025
Q1 		$1.02M Sell
30,000
-98,500
-77% -$4.18M 0.01% 909
2024
Q4 		$5.06M Buy
+128,500
New +$6.07M 0.05% 369
2024
Q3 		– Sell
-55,000
Closed -$2.97M – 1345
2024
Q2 		$2.97M Sell
55,000
-240,000
-81% -$13.9M 0.05% 395
2024
Q1 		$20.1M Sell
295,000
-105,000
-26% -$7.52M 0.31% 67
2023
Q4 		$25M Buy
400,000
+370,000
+1,233% +$20.5M 0.34% 60
2023
Q3 		$1.36M Sell
30,000
-140,000
-82% -$7.23M 0.02% 685
2023
Q2 		$9.54M Buy
+170,000
New +$9.65M 0.17% 149
2022
Q3 		– Sell
-20,000
Closed -$1.22M – 1563
2022
Q2 		$1.22M Hold
20,000
– – 0.02% 814
2022
Q1 		$1.26M Buy
20,000
+5,000
+33% +$314K 0.02% 890
2021
Q4 		$1.14M Buy
+15,000
New +$1.31M 0.01% 998
2021
Q3 		– Sell
-42,000
Closed -$6.8M – 1558
2021
Q2 		$6.8M Buy
+42,000
New +$5.11M 0.09% 292
2020
Q3 		– Sell
-130,000
Closed -$9.55M – 1064
2020
Q2 		$9.55M Buy
+130,000
New +$7.6M 0.32% 60

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Caption Management's CRSP Position: Q2 2025 in Review

Caption Management sold out of CRISPR Therapeutics (CRSP) in Q2 2025, closing a stake of 3,383 shares — an estimated $131K sold.

Caption Management first reported a position in CRSP in Q2 2018 and held it in 7 quarters. The position peaked at $1.3M in Q2 2024. 433 funds tracked by Wall St. Rank hold CRSP as of Q2 2025.

  • Caption Management reported no remaining CRISPR Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Caption Management sold 3,383 CRISPR Therapeutics shares in Q2 2025, an estimated $131K.
  • Caption Management first reported a position in CRISPR Therapeutics in Q2 2018 and held it in 7 quarters.
  • Caption Management's CRISPR Therapeutics position peaked at $1.3M in Q2 2024.
  • 433 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.